DongBang Future Tech & Life Co., Ltd
Is this your company? Claim this profile
Drug Substance
Drug Product
Manufacturing & Lab Equipment
Company Overview
About
DongBang Future Tech & Life Co., Ltd is a South Korean pharmaceutical company founded in 1990 that operates as a CDMO for chemical APIs and finished drugs. The company specializes in HPAPI, PROTAC, and hybrid small molecule development, with 35+ active CMC and CDMO projects for global pharma and biotech companies.
Key Expertise
HPAPI, PROTAC, Small Molecule API, Chemical API CMC, Hybrid Small Molecules
Therapeutic Areas
Cardiovascular
Quick Facts
HQ:South Korea
Capabilities & Services
Core Capabilities
- Small Molecule API
- API Manufacturing
- Process Development
Markets Served
Asia
Manufacturing Facilities
1 site worldwide
DongBang Future Tech & Life Co., Ltd - South Korea Facility
South Korea
Site Capabilities
3 capabilitiesFormulation Development
Process Development
Scale-up